Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors

BACKGROUND: Overexpression of the gastrin-releasing peptide receptor (GRP-R) has been documented in several human neoplasms such as breast, prostate, and ovarian cancer. There is growing interest in developing radiolabeled peptide-based ligands toward these receptors for the purpose of in vivo imagi...

Descripción completa

Detalles Bibliográficos
Autores principales: Accardo, Antonella, Galli, Filippo, Mansi, Rosalba, Del Pozzo, Luigi, Aurilio, Michela, Morisco, Anna, Ringhieri, Paola, Signore, Alberto, Morelli, Giancarlo, Aloj, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761355/
https://www.ncbi.nlm.nih.gov/pubmed/26897133
http://dx.doi.org/10.1186/s13550-016-0175-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761355/
https://www.ncbi.nlm.nih.gov/pubmed/26897133
http://dx.doi.org/10.1186/s13550-016-0175-x

Ejemplares similares